DG Daiwa Ventures contributed to a $40m series B round for Yellow Card Financial while Vitol provided $37m in series C funding for VavaCars.
Alphabet led a $1bn round for its life sciences unit, PTT bets on insect startup and corporate-backed Propzy is set to shut down.
Job moves in the investment arms of telecoms companies over the past year, many of them involving rotation at SoftBank.
Telefónica Ventures head of investments Pablo Moro tells Global Venturing Web3 and the metaverse are now among its priorities, with play-to-earn, tokenisation, VR and AR among the potential strategic areas.
As telecoms networks continue to expand their services, what even counts as a strategic investment these days? A selection of industry figures tell Global Venturing it can include Web3, ESG and 5G-related technologies.
Pfizer Ventures has hired Irena Melnikova, formerly CFO of Umoja Biopharma and MD of SVB Leerink, as an executive director.
Invest in a business development function — early. Be creative with funding and careful with how your strategic value is measured.
Pfizer Ventures has led a $102m series A for Capstan Therapeutics while Globis Capital Partners took part in an $85.4m round for Andpad.
Danilo Gaspar has been hired by the Brazilian medical education and digital health tool provider as head of corporate venture capital.
Access Industries, Pfizer and SR One were among the investors in a $125m round for Nimbus Therapeutics while Aerwins agreed a reverse takeover.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
